Phio Pharmaceuticals Corp.
PHIO
$1.22
-$0.04-3.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 21.03M | 10.71M | 10.78M | 13.28M | 5.38M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 445.00K | 788.00K | 519.00K | 158.00K | 354.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 21.48M | 11.49M | 11.29M | 13.44M | 5.74M |
|
|
|||||
| Total Current Assets | 21.48M | 11.49M | 11.29M | 13.44M | 5.74M |
| Net Property, Plant & Equipment | 11.00K | 12.00K | 7.00K | 4.00K | 2.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 21.49M | 11.51M | 11.30M | 13.44M | 5.74M |
|
|
|||||
| Total Accounts Payable | 435.00K | 516.00K | 235.00K | 427.00K | 253.00K |
| Total Accrued Expenses | 905.00K | 1.15M | 971.00K | 843.00K | 762.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.34M | 1.67M | 1.21M | 1.27M | 1.02M |
|
|
|||||
| Total Current Liabilities | 1.34M | 1.67M | 1.21M | 1.27M | 1.02M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.34M | 1.67M | 1.21M | 1.27M | 1.02M |
|
|
|||||
| Common Stock & APIC | 175.20M | 162.52M | 160.39M | 160.30M | 151.08M |
| Retained Earnings | -155.05M | -152.68M | -150.29M | -148.13M | -146.36M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 20.15M | 9.84M | 10.10M | 12.17M | 4.72M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 20.15M | 9.84M | 10.10M | 12.17M | 4.72M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.15M | 9.84M | 10.10M | 12.17M | 4.72M |
|
|
|||||